Abstract: Small round blue cell tumor is a very common diagnostic finding after intraoperative
Introduction
Esthesioneuroblastoma is an extremelyrare neoplasm with an incidence of 0.4 per 1,000,000 people. 1 it is a locally aggressive idiopathic neoplasm of sinonasal area arising from olfactory neuroepithelium and its clinical course is characterised by indolent growth, persistent local recurrence and occasional distant metastasis. It has a wide range of age presentation (3 -79yrs), mostly showing bimodal age distribution which peaks around first and fifth decade 2, 3 . Its probable site of origin is neuroectodermal. Being more precise, it is believed to originate from sustentacular cells of olfactory neuroepithelium in upper third of nasal septum, cribriform plate and superior turbinate. It has been given various terminologies such as olfactory placode tumor, esthesioneurocytoma, esthesioneuroepithelioma, and esthesioneuroma. It is classified into 4 grades on the basis of Hyam's histological grading. Extent and survival rate is classified by Kaddish clinical staging system as discussed later.
Case history
As found in various studies, Esthesioneuroblastoma typically presents with unilateral nasal obstruction or epistaxis. [4] [5] [6] Craniofacial resection en bloc is the surgery of choice for Esthesioneuroblastoma. In Third case endoscopic craniofacial resection was done for the child.In second case bone resection and graft placement was also followed the basic operative procedure.In the first case, dacryocystorhinostomyand frontal sinusotomy was also planned which couldn't be executed due to on-table death. During operative procedures, first case was described as Kadish stage D due to the tumor metastasis to distant cervical lymph nodes, Second case was established as Kadish stage C due to extension beyond paranasal sinuses. The tumor was so aggressive that it eroded the frontal, maxillary bone and orbital wall. Third case which affected a young child was observed as Kadish stage B due to its limitation to paranasal sinuses.
Macroscopic Features -In first case it was a lobulated mass measuring 10x3x3 cm greyish white in colour, firm in consistency. Cut open section showed few necrosed and calcification areas. In the second case, 
Discussion
Esthesioneuroblastoma is mostly classified under two broader diagnostic terms sinonasal neuroendocrine malignancies or small round blue cell tumors. The differential diagnosis which should be considered are Malignant lymphoma(NHL), primary melanoma, Plasmacytoma, Embryonal/ alveolar rhabdomyosarcoma, Ewing sarcoma/ primitive neuroectodermal tumour, Sinonasal Undifferentiated carcinoma, Sinonasal neuroendocrine carcinoma and Small cell carcinoma. Though the patient presents with the symptoms quite late, early diagnosis is very important due to complex anatomical site and aggressiveness of the tumor. The pathologic grading system for Esthesioneuroblastomadeveloped by Hyam's is as follows:- Grade I tumors have excellent prognosis and grade IV have worst prognosis with uniformly fatal outcome. For staging purposes, the best known and widely used system is that devised by Kadish [7] and modified by Morita.
[8]
Kadish Staging with Morita's Modification
A -Limited to nasal cavity 75-90% B -Involving nasal cavity &sinuses 67-71% C -Extension beyond nasal & paranasal sinuses cavities 41-47% D -Tumor with metastasis to cervical nodes or distant sites <40% Thus, it is important to clinically stage the tumor and histologically grade followed by prompt resection.It is important to follow-up the patient post-operatively due its high recurrence rate. The reported locoregional recurrence rate in Esthesioneuroblastoma ranges from27 to 62% with most recurrences within first two years of diagnosis [9, 10] .Few paraneoplastic syndromes have also been reported, most common being Syndrome of inappropriate Antidiuretic hormone secretion. 11 Henceforth, it is important to diagnose the patient of Esthesioneuroblastoma as soon as possible and resect the tumor along with tumor margins followed by radiotherapy and chemotherapy.
